The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Evaluation of therapeutic targets in animal models of arthritis: How does it relate to rheumatoid arthritis?
Abstract
Introduction Rheumatoid arthritis (RA) is a chronic, systemic, immune-mediated inflammatory disease associated with decreased life expectancy and quality of life. RA is characterized by chronic inflammation and synovial hyperplasia leading to destruction of cartilage and bone. A better understanding of the pathophysiology of RA has led to significant improvements in its treatment. However, many questions remain with respect to the pathogenesis of RA, and disease remission is achieved in only a minority of patients. Therefore, there is still a need to develop novel antirheumatic therapies. Animal models of RA complement descriptive studies of well-defined patient samples and in vitro studies and represent important tools for the development and evaluation of new treatment options. This review article addresses the immunologic characteristics of and similarities and differences between a variety of animal models of human RA. Commonly used animal models such as collagen-induced arthritis (CIA), adjuvant-induced arthritis (AIA), and a model of spontaneous arthritis using tumor necrosis factor (TNF)–transgenic mice are described. We also discuss the less frequently used models of streptococcal cell wall (SCW)–induced arthritis, proteoglycan-induced arthritis (PGIA), and K/BxN-transgenic mice, including the serum transfer–induced (STIA) model, to indicate the variety of animal models with specific characteristics that are available and that could be used to study specific components and stages of the inflammation process. Furthermore, we describe the effects of some targeted interventions, comparing animal studies with clinical trials. Finally, the importance of choosing a suitable animal model of arthritis for screening the preclinical efficacy of newly developed therapeutics is addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
American college of rheumatology preliminary definition of improvement in rheumatoid arthritis
Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Furst, D., Goldsmith, C., Katz, L. M., Lightfoot, R., Paulus, H., Strand, V., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380602 · Cited by 2,829
Cytokines in the pathogenesis of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2094 · Cited by 2,529
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Self-citationEmery, P., Keystone, E., Tony, H. P., Cantagrel, A., van Vollenhoven, R., Sanchez, A., Alecock, E., Lee, J., & Kremer, J. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092932 · Cited by 1,104
Evidence that cytokines play a role in rheumatoid arthritis
Brennan, F. M., & McInnes, I. B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36389 · Cited by 1,103
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
Elliott, M. J., Maini, R. N., Feldmann, M., Long‐Fox, A., Charles, P., Katsikis, P., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361206 · Cited by 1,038
Immunisation against heterologous type II collagen induces arthritis in mice
Courtenay, J. S., Dallman, M. J., Dayan, A. D., Martin, A., & Mosedale, B. (1980) · Nature · doi:10.1038/283666a0 · Cited by 1,025
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 989
Development of Arthritis, Periarthritis and Periostitis in Rats Given Adjuvants.
Pearson, C. M. (1956) · Experimental Biology and Medicine · doi:10.3181/00379727-91-22179 · Cited by 842
Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis
Eden, W. V., Tholet, J. E. R., Zee, R. V. D., Noordzij, A., van Embden, J. D. A., Hensen, E. J., & Cohen, I. R. (1988) · Nature · doi:10.1038/331171a0 · Cited by 822
From Systemic T Cell Self-Reactivity to Organ-Specific Autoimmune Disease via Immunoglobulins
Korganow, A.-S., Ji, H., Mangialaio, S., Duchatelle, V., Pelanda, R., Martin, T., Degott, C., Kikutani, H., Rajewsky, K., Pasquali, J.-L., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80045-x · Cited by 690
Interleukin-1 Receptor Antagonist
Arend, W. P. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60535-0 · Cited by 671
Tak, P. P., Smeets, T. J. M., Daha, M. R., Kluin, P. M., Meijers, K. A. E., Brand, R., Meinders, A. E., & Breedveld, F. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400206 · Cited by 548
Self-citationKeystone, E. C., Genovese, M. C., Klareskog, L., Hsia, E. C., Hall, S. T., Miranda, P. C., Pazdur, J., Bae, S.-C., Palmer, W., Zrubek, J., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.099010 · Cited by 541
Schiff, M., Keiserman, M., Codding, C., Songcharoen, S., Berman, A., Nayiager, S., Saldate, C., Li, T., Aranda, R., Becker, J.-C., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.080002 · Cited by 539
Smolen, J. S., Kay, J., Doyle, M. K., Landewé, R., Matteson, E. L., Wollenhaupt, J., Gaylis, N., Murphy, F. T., Neal, J. S., Zhou, Y., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60506-7 · Cited by 526
IL-33 exacerbates antigen-induced arthritis by activating mast cells
Xu, D., Jiang, H.-R., Kewin, P., Li, Y., Mu, R., Fraser, A. R., Pitman, N., Kurowska-Stolarska, M., McKenzie, A. N. J., McInnes, I. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801898105 · Cited by 464
Arthritis in rats after systemic injection of streptococcal cells or cell walls.
Cromartie, W. J., Craddock, J. G., Schwab, J. H., Anderle, S. K., & Yang, C. H. (1977) · The Journal of experimental medicine · doi:10.1084/jem.146.6.1585 · Cited by 438
Moreland, L. W., Alten, R., Van Den Bosch, F., Appelboom, T., Leon, M., Emery, P., Cohen, S., Luggen, M., Shergy, W., Nuamah, I., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10294 · Cited by 383
Loo, F. A. J. V. D., Joosten, L. A. B., Van Lent, P. L. E. M., Arntz, O. J., & Van Den Berg, W. B. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380204 · Cited by 380
A Prescription for Human Immunology
Davis, M. M. (2008) · Immunity · doi:10.1016/j.immuni.2008.12.003 · Cited by 345
Animal models of rheumatoid arthritis
Asquith, D. L., Miller, A. M., McInnes, I. B., & Liew, F. Y. (2009) · European Journal of Immunology · doi:10.1002/eji.200939578 · Cited by 345
Fleischmann, R., Vencovsky, J., van Vollenhoven, R. F., Borenstein, D., Box, J., Coteur, G., Goel, N., Brezinschek, H.-P., Innes, A., & Strand, V (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.099291 · Cited by 338
Stuart, J. M., Cremer, M. A., Townes, A. S., & Kang, A. H. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.1.1 · Cited by 334
Critical Roles for Interleukin 1 and Tumor Necrosis Factor α in Antibody-induced Arthritis
Ji, H., Pettit, A., Ohmura, K., Ortiz-Lopez, A., Duchatelle, V., Degott, C., Gravallese, E., Mathis, D., & Benoist, C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020439 · Cited by 332
Utility of animal models for identification of potential therapeutics for rheumatoid arthritis
Hegen, M., Keith, J. C., Collins, M., & Nickerson-Nutter, C. L. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.076430 · Cited by 305
Proteoglycan‐induced arthritis in balb/c mice
Glant, T. T., Mikecz, K., Arzoumanian, A., & Poole, A. R. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300211 · Cited by 304
Animal models of arthritis: relevance to human disease.
Bendele, A., Mccomb, J., Gould, T., Mcabee, T., Sennello, G., Chlipala, E., & Guy, M. (1999) · Toxicologic Pathology · doi:10.1177/019262339902700125 · Cited by 293
Wooley, P. H., Dutcher, J., Widmer, M. B., & Gillis, S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.11.6602 · Cited by 293
Young, D. A., Hegen, M., Ma, H. L. M., Whitters, M. J., Albert, L. M., Lowe, L., Senices, M., Wu, P. W., Sibley, B., Leathurby, Y., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22452 · Cited by 275
Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis
Takagi, N., Mihara, M., Moriya, Y., Nishimoto, N., Yoshizaki, K., Kishimoto, T., Takeda, Y., & Ohsugi, Y. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2117::aid-art6>3.0.co;2-p · Cited by 270
Genovese, M. C., Schiff, M., Luggen, M., Becker, J.-C., Aranda, R., Teng, J., Li, T., Schmidely, N., Le Bars, M., & Dougados, M. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.074773 · Cited by 264
Bush, K. A., Farmer, K. M., Walker, J. S., & Kirkham, B. W. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10173 · Cited by 252
Webb, L. M. C., Walmsley, M. J., & Feldmann, M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261008 · Cited by 239
Animal models of rheumatoid arthritis and their relevance to human disease
Kannan, K., Ortmann, R. A., & Kimpel, D. (2005) · Pathophysiology · doi:10.1016/j.pathophys.2005.07.011 · Cited by 238
Inhibitor of nuclear factor ?B kinase ? is a key regulator of synovial inflammation
Tak, P. P., Gerlag, D. M., Aupperle, K. R., Geest, D. A. V. D., Overbeek, M. J., Bennett, B. L., Boyle, D. L., Manning, A. M., & Firestein, G. S. (2001) · Arthritis & Rheumatism · Cited by 234
Self-citationImmunopathogenesis of Collagen Arthritis
Brand, D. D., Kang, A. H., & Rosloniec, E. F. (2003) · Springer Seminars in Immunopathology · doi:10.1007/s00281-003-0127-1 · Cited by 230
Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Burmester, G. R., Bijlsma, J. W. J., Dougados, M., Emery, P., Keystone, E. C., Klareskog, L., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.044941 · Cited by 225
Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice
Sasai, M., Saeki, Y., Ohshima, S., Nishioka, K., Mima, T., Tanaka, T., Katada, Y., Yoshizaki, K., Suemura, M., & Kishimoto, T. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199908)42:8<1635::aid-anr11>3.0.co;2-q · Cited by 208
Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis
Cho, Y.-G., Cho, M.-L., Min, S.-Y., & Kim, H.-Y. (2007) · Autoimmunity Reviews · doi:10.1016/j.autrev.2007.08.001 · Cited by 202
The genetic and immunopathological processes underlying collagen‐induced arthritis
Luross, J. A., & Williams, N. A. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01267.x · Cited by 199
The TNF-? transgenic mouse model of inflammatory arthritis
Li, P., & Schwarz, E. M. (2003) · Springer Seminars in Immunopathology · doi:10.1007/s00281-003-0125-3 · Cited by 191
Protocol for the induction of arthritis in C57BL/6 mice
Inglis, J. J., Šimelyte, E., McCann, F. E., Criado, G., & Williams, R. O. (2008) · Nature Protocols · doi:10.1038/nprot.2008.19 · Cited by 187
Anakinra for rheumatoid arthritis
Mertens, M., & Singh, J. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005121.pub3 · Cited by 179
Alten, R., Gram, H., Joosten, L. A., Berg, W. B. V. D., Sieper, J., Wassenberg, S., Burmester, G., van Riel, P., Diaz-Lorente, M., Bruin, G. J., et al. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2438 · Cited by 170
The clinical utility of inhibiting CD28‐mediated costimulation
Linsley, P. S., & Nadler, S. G. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00780.x · Cited by 162
Bendele, A. M., McAbee, T., Sennello, G., Frazier, J., Chlipala, E. A., & McCabe, D. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199904)42:3<498::aid-anr15>3.0.co;2-a · Cited by 155
Schwab, J. H., Anderle, S. K., Brown, R. R., Dalldorf, F. G., & Thompson, R. C. (1991) · Infection and Immunity · doi:10.1128/iai.59.12.4436-4442.1991 · Cited by 152
Staging the Initiation of Autoantibody-Induced Arthritis: A Critical Role for Immune Complexes
Wipke, B. T., Wang, Z., Nagengast, W. B., Reichert, D. E. C., & Allen, P. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7694 · Cited by 148
Schubert, D. A., Maier, B., Morawietz, L., Krenn, V., & Kamradt, T. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4503 · Cited by 144
Nandakumar, K. S., & Holmdahl, R. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2089 · Cited by 139
Kleinau, S., Erlandsson, H., Holmdahl, R., & Klareskog, L. (1991) · Journal of Autoimmunity · doi:10.1016/0896-8411(91)90050-m · Cited by 138
INTERLEUKIN 6 KNOCK-OUT MICE ARE RESISTANT TO ANTIGEN-INDUCED EXPERIMENTAL ARTHRITIS
Boe, A., Baiocchi, M., Carbonatto, M., Papoian, R., & Serlupi‐Crescenzi, O. (1999) · Cytokine · doi:10.1006/cyto.1999.0502 · Cited by 132
Proteoglycan-Induced Arthritis: Immune Regulation, Cellular Mechanisms, and Genetics
Glant, T. T., Finnegan, A., & Mikecz, K. (2003) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v23.i3.20 · Cited by 129
O’Neill, S. K., Cao, Y., Hamel, K. M., Doodes, P. D., Hutás, G., & Finnegan, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5109 · Cited by 128
Rioja, I., Bush, K., Buckton, J. B., Dickson, M. C., & Life, P. F. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02499.x · Cited by 122
Cryopyrin-associated periodic syndromes and autoinflammation
Shinkai, K., McCalmont, T. H., & Leslie, K. S. (2007) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2007.02540.x · Cited by 121
Interleukin-6 in the pathogenesis of rheumatoid arthritis.
Park, J. Y., & Pillinger, M. H. (2007) · PubMed · Cited by 119
Neurath, M. F., Hildner, K., Becker, C., Schlaak, J., Barbulescu, K., Germann, T., Schmitt, E., Schirmacher, P., Haralambous, S., Pasparakis, M., et al. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.00753.x · Cited by 118
Collagen-Induced Arthritis as a Model of Rheumatoid Arthritis
Duris, F. H., Fava, R. A., & Noelle, R. J. (1994) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1994.1164 · Cited by 115
Feige, U., Hu, Y.-L., Gasser, J. A., Campagnuolo, G., Munyakazi, L., & Bolon, B. N. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000629 · Cited by 111
Interleukin-6 inhibitors in the treatment of rheumatoid arthritis
Hennigan, S., & Kavanaugh, A. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3470 · Cited by 110
The KRN mouse model of inflammatory arthritis
Kyburz, D., & Corr, M. (2003) · Springer Seminars in Immunopathology · doi:10.1007/s00281-003-0131-5 · Cited by 107
Usón, J., Balsa, A., Pascual‐Salcedo, D., Cabezas, J. A., Gonzalez-Tarrio, J., Martín-Mola, E., & Fontán, G. (1997) · PubMed · Cited by 106
Development of Proteoglycan-Induced Arthritis Is Independent of IL-17
Doodes, P. D., Cao, Y., Hamel, K. M., Wang, Y., Farkas, B., Iwakura, Y., & Finnegan, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.329 · Cited by 98
Holmdahl, R., Jonsson, R., Larsson, P., et al. (1988) · PubMed · Cited by 93
Joosten, L. A. B., Abdollahi‐Roodsaz, S., Heuvelmans‐Jacobs, M., Helsen, M. M. A., van den Bersselaar, L. A. M., Oppers‐Walgreen, B., Koenders, M. I., & van den Berg, W. B. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23152 · Cited by 90
van Lent, P. L., van de Loo, F. A. J., Holthuysen, A. E. M., et al. (1995) · PubMed · Cited by 86
Collagen-Induced Arthritis in Mice
Bevaart, L., Vervoordeldonk, M. J., & Tak, P. P. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-058-8_11 · Cited by 85
Self-citationHanyecz, A., Berlo, S. E., Szántó, S., Broeren, C. P. M., Mikecz, K., & Glant, T. T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20180 · Cited by 84
Griffiths, M. M., & Dewitt, C. W. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.6.2830 · Cited by 74
Animal models of rheumatoid arthritis
Joe, B., & Wilder, R. L. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01528-2 · Cited by 74
Koga, T., Kakimoto, K., Hirofuji, T., Kotani, S., Ohkuni, H., Watanabe, K., Okada, N., Okada, H., Sumiyoshi, A., & Saisho, K. (1985) · Infection and Immunity · doi:10.1128/iai.50.1.27-34.1985 · Cited by 72
Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor α
Williams, R. O., Feldmann, M., & Maini, R. N. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.suppl_1.i75 · Cited by 67
Schrier, D. J., Schimmer, R. C., Flory, C. M., Tung, D. K.-L., & Ward, P. A. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.63.3.359 · Cited by 58
Broere, F., Wieten, L., Koerkamp, E. K., van Roon, J. A. G., Guichelaar, T., Lafeber, F. P. J. G., & van Eden, W. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.899 · Cited by 55
Scheinecker, C., Smolen, J., Yasothan, U., Stoll, J., & Kirkpatrick, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2863 · Cited by 49
van den Broek, M. F., van den Berg, W. B., van de Putte, L. B., & Severijnen, A. J. (1988) · PubMed · Cited by 48
Functional analysis of an arthritogenic synovial fibroblast
Aidinis, V., Plows, D., Haralambous, S., Armaka, M., Papadopoulos, P., Kanaki, M., Koczan, D., Thiesen, H.-J., & Kollias, G. A. (2003) · Arthritis Research & Therapy · doi:10.1186/ar749 · Cited by 47
Matsumoto, I., Zhang, H., Yasukochi, T., Iwanami, K., Tanaka, Y., Inoue, A., Goto, D., Ito, S., Tsutsumi, A., & Sumida, T. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2437 · Cited by 45
Kliwinski, C. M., Kukral, D. W., Postelnek, J., Krishnan, B. S., Killar, L. M., Lewin, A. C., Nadler, S. G., & Townsend, R. C. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.09.020 · Cited by 43
Probert, L., Akassoglou, K., Alexopoulou, L., Douni, E. K., Haralambous, S., Hill, S., Kassiotis, G., Kontoyiannis, D. L., Pasparakis, M., Plows, D., et al. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.59.4.518 · Cited by 41
Dynamics of Early Synovial Cytokine Expression in Rodent Collagen-Induced Arthritis
Palmblad, K., Erlandsson-Harris, H., Tracey, K. J., & Andersson, U. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63991-0 · Cited by 40
Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis
Liang, B., Song, Z., Wu, B., Gardner, D. B., Shealy, D. J., Song, X.-Y., & Wooley, P. H. (2009) · Journal of Inflammation · doi:10.1186/1476-9255-6-10 · Cited by 40
The determinants of susceptibility/resistance to adjuvant arthritis in rats
Kim, E. Y., & Moudgil, K. D. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2755 · Cited by 38
Magari, K., Miyata, S., Ohkubo, Y., & Mutoh, S. (2004) · Inflammation Research · doi:10.1007/s00011-004-1284-y · Cited by 35
Heat shock protein 60 reactive T cells in juvenile idiopathic arthritis: what is new?
Vercoulen, Y., van Teijlingen, N. H., de Kleer, I. M., Kamphuis, S., Albani, S., & Prakken, B. J. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2674 · Cited by 33
Tarjanyi, O., Boldizsar, F., Nemeth, P., Mikecz, K., & Glant, T. T. (2009) · Immunity & Ageing · doi:10.1186/1742-4933-6-8 · Cited by 32
The role of neutrophils in type II collagen-induced arthritis in rats.
Schrier, D. J., Rb, G., Lesch, M. E., & Fantone, J. C. (1984) · PubMed · Cited by 32
Splenectomy attenuates streptococcal cell wall–induced arthritis and alters leukocyte activation
Kimpel, D. L., Dayton, T., Fuseler, J. W., Gray, L. T., Kannan, K., Wolf, R. E., & Grisham, M. B. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11424 · Cited by 29
Schimmer, R. C., Schrier, D. J., Flory, C. M., Laemont, K. D., Tung, D., Metz, A. L., Friedl, H. P., Conroy, M. C., Warren, J. S., Beck, B., et al. (1998) · PubMed · Cited by 29
The role and clinical implications of G6PI in experimental models of rheumatoid arthritis.
Kamradt, T., & Schubert, D. A. (2005) · Arthritis Research · doi:10.1186/ar1476 · Cited by 27
Gene Array Analysis Comparison between Rat Collagen‐induced Arthritis and Human Rheumatoid Arthritis
Soto, H., Hevezi, P. A., Roth, R. B., Pahuja, A., Alleva, D. G., Acosta, H., Martinez, C., Ortega, A., Lopez, A., Araiza-Casillas, R., et al. (2008) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2008.02117.x · Cited by 26
Choy, E. (2009) · PubMed · Cited by 26
Koffeman, E. C., Prakken, B. J., & Albani, S. (2005) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000171213.49876.f6 · Cited by 7
Neidhart (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200012)43:12 · Cited by 1
Tsuchihashi (2000) · doi:10.1002/1521-4141(200006)30:6
Cited by
Tests and models of nociception and pain in rodents
Barrot, M. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.041 · Cited by 483
Keystone, E. C., Wang, M. M., Layton, M., Hollis, S., & McInnes, I. B. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-143578 · Cited by 315
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity
Zhang, Q., & Vignali, D. A. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.017 · Cited by 296
Experimental animal models for rheumatoid arthritis
Choudhary, N., Bhatt, L. K., & Prabhavalkar, K. S. (2018) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2018.1434793 · Cited by 295
T cell migration in rheumatoid arthritis
Mellado, M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00384 · Cited by 291
Metadata
- Authors
- Bevaart, L., Vervoordeldonk, M. J., & Tak, P. P.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2010-08
- Volume
- 62
- Issue
- 8
- Pages
- 2192-2205
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2140016144
- Cited by
- 253
- References
- 98
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.